Skip to content

APOTHEEK VERSTEELE

Active Private limited companyfounded 2000active for 26 yearsNoordstraat 27, 8630 VeurneKBO/BCE: BE 0472.673.377

Lifetime

20 annual accounts with figures on one time axis, 25 filings since 2001
peak of €349,476 in 2025
€349,476▲ 14.8%
peak of €129,556 in 2022
€67,377▲ 36.4%
peak of €821,055 in 2025
€821,055▲ 8.9%
€359,216▼ 32.4%
peak of 3.3 FTE in 2025
3.3 FTE▲ 10.0%
Board1 name since 2023
1 director
Documentsfilings and deeds
04-06-202657 days before the deadline
2025abbreviated format
Gross margin from €304,480 to €349,476Result from €49,379 to €67,377Staff from 3 FTE to 3.3 FTEDebts from €531,040 to €359,216Cash from €25,554 to €38,102

Key points

from the 2025 annual accounts

Equity

€821,055 ▲ 8.9%

APOTHEEK VERSTEELE has made a profit in every financial year since 2006.

Turnover

≈ €1.2m estimated

The abbreviated format states no turnover.

Staff

4 employees on 31-12-2025
222022302024562025

In 2025, 5 employees joined and 6 left.

Liquidity

2.10 was 1.28 in 2024

Short-term debts fell from €381,326 to €217,011.

Filings

25 annual accounts since 2001
AprilJune31 JulyOctober20102020

The last five annual accounts were filed 6 to 122 days before the end of the period.

Position in the sector

69.6%

Higher solvency than 82% of companies in retail trade. The sector median is 36.8%, over 13,315 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 31,390 companies had the same profile as APOTHEEK VERSTEELE has now. Each dot stands for 79 companies, two years later.

93.4%
were still trading
6.0%
stopped another way
0.5%
went bankrupt
  • Micro
  • 20 years or older
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more

Another 0.1% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,994 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 31,390 companies, not a prediction for APOTHEEK VERSTEELE. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director,
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0472673377
appointed as director General meeting of 01-10-2024 · Gazette deed
1 director appointed, 1 resignation resigns · appointed · acts as permanent representative · General meeting of 03-01-2024 · Gazette deed
changes role from manager to director Discharge granted to · General meeting of 21-04-2021 · Gazette deed
All 35 events

Comparable companies

same main activity, similar in size and age
Company
APOTHEEK VERSTEELE Veurne €1.2m €349,476 69.6% 3.3
SANOPHAR Menen €1.2m €352,673 40.9% 2.9
Apotheek Greet VERSTRAETE Wingene €1.2m €324,173 77.6% 3.5
APOTHEEK LAURYSSEN Antwerp €1.2m €335,487 7.8% 3.1
LOMA PHARMA Izegem €1.2m €420,865 31.2% 3.9
PHARMACIE LEDOUX - POZZI Anhée €1.1m €333,395 34.0% 2.9
Pharmacie POLAIN Oupeye €1.2m €344,980 34.1% 3.1

These companies have the same main activity as APOTHEEK VERSTEELE: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €1.1m and €1.2m, founded between 1997 and 2005.

Official details

Source: KBO
Status
Active since 04-09-2000Normal situation
Activity
Retail sale of pharmaceutical productsNACE 47730
Joint committee
313Pharmacies and pricing offices · annual accounts 2022
Establishment unit
2.116.012.6368630 Veurne, since 30-10-2000
Financial year end
31 December
Peppol
Reachable since 13-05-2026
Company details

Annual accounts 2025

€1.2m▼ 8.1%
Employeeson 31-12-2025
4▼ 20.0%
Filing
Filed on 04-06-2026, 57 days before the end of the filing period
Financials

Insights on APOTHEEK VERSTEELE

APOTHEEK VERSTEELE files the abbreviated format. That format states no turnover. The gross margin rose from €214,396 in 2006 to €349,476 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about APOTHEEK VERSTEELE

What is the company number of APOTHEEK VERSTEELE?
The company number of APOTHEEK VERSTEELE is 0472.673.377. The VAT number is the same number with BE in front: BE 0472.673.377.
Where is APOTHEEK VERSTEELE based?
The registered office is at Noordstraat 27, 8630 Veurne.Company details
What does APOTHEEK VERSTEELE do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of APOTHEEK VERSTEELE?
APOTHEEK VERSTEELE is a private limited company (BV).
When was APOTHEEK VERSTEELE founded?
APOTHEEK VERSTEELE was founded on 04-09-2000.
Is APOTHEEK VERSTEELE still active?
Yes, APOTHEEK VERSTEELE is an active enterprise in the KBO register.
How many employees does APOTHEEK VERSTEELE have?
APOTHEEK VERSTEELE had an average of 3.3 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
Which joint committee does APOTHEEK VERSTEELE fall under?
In its 2022 annual accounts, APOTHEEK VERSTEELE states joint committee 313 (Pharmacies and pricing offices).
What is the turnover of APOTHEEK VERSTEELE?
The turnover in financial year 2025 is about €1.2m. This figure is estimated from the gross margin of €349,476 and 42 comparable companies (NACE 477). It probably lies between €950,000 and €1.7m.
Is APOTHEEK VERSTEELE profitable?
In financial year 2025, APOTHEEK VERSTEELE made a profit of €67,377.
Where can I find the annual accounts of APOTHEEK VERSTEELE?
APOTHEEK VERSTEELE filed 25 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of APOTHEEK VERSTEELE due?
APOTHEEK VERSTEELE must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.